Alternatives to Dio Tree

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered blood test for early cancer detection and subtyping.

Biotechnology company developing novel therapies for multiple myeloma.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Compressing biology to develop the next generation of therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.